about
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP aut...
Read More
1.26
-0.01
(-0.79%)
36,700
XNAS Volume
XNAS 13 Mar, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
BioCardia Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..